The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer Brokerages are positive on prospects of Glenmark Life Sciences IPO. BusinessToday.In
Updated Jul 28, 2021, 10:27 AM IST
The initial public offer (IPO) of Glenmark Life Sciences was fully subscribed on its first day on Tuesday. The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer.
The portion reserved for retail investors was subscribed 5.16 times.
Portion allocated for non-institutional investors was subscribed 85 percent. Qualified institutional buyers put in bids for 10,540 equity shares against their reserved portion of 42.42 lakh equity shares.
The IPO will close on July 29. Price band for the offer has been fixed at Rs 695-720 per equity share.
Markets to remain volatile ahead of F&O expiry - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
IPO Update: Glenmark Life Sciences IPO subscribed 3 27 times on Day 2
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.